|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2006
Association between lipid peroxidation and inflammation in obstructive sleep apnoea
1 First Dept of Internal Medicine, Showa University, 2 Division of Diabetes and Endocrinology, Toho University, Tokyo, Japan. 3 Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
CORRESPONDENCE: K. Minoguchi, First Dept of Internal Medicine, Showa University, School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan. Fax: 81 337848742. E-mail: minochan{at}fn.catv.ne.jp
Keywords: Cardiovascular diseases, C-reactive protein, hypoxia, inflammation, oxidative stress, sleep apnoea
Received: July 21, 2005
Accepted March 22, 2006
In the present study, the authors examined the relationship between lipid peroxidation and inflammation in patients with obstructive sleep apnoea (OSA).
A total of 40 obese patients with OSA were studied, along with 18 obese and 12 lean subjects without OSA. Overnight excretion of 8-isoprostane in urine and serum levels of high-sensitivity C-reactive protein (hsCRP) were measured. In addition, the effects of 3 months’ treatment with nasal continuous positive airway pressure (nCPAP) were studied in 20 obese patients with moderate-to-severe OSA.
Overnight urinary excretion of 8-isoprostane and serum levels of hsCRP were significantly higher in patients with moderate-to-severe OSA compared with patients with mild OSA and obese or lean subjects without OSA. Overnight urinary excretion of 8-isoprostane significantly correlated with apnoea–hypopnoea index, duration of hypoxia during sleep, body mass index, and serum levels of hsCRP in patients with OSA. The severity of OSA was an independent factor predicting the urinary excretion of 8-isoprostane. nCPAP significantly decreased urinary excretion of 8-isoprostane and serum levels of hsCRP.
In conclusion, these results suggest that both obstructive sleep apnoea severity and obesity can independently contribute to elevations in urinary excretion of 8-isoprostane. Therefore, obstructive sleep apnoea may increase the risks of cardiovascular morbidity in obese patients.
This article has been cited by other articles:
|
|
 |
|
  J. A. Dempsey, S. C. Veasey, B. J. Morgan, and C. P. O'Donnell Pathophysiology of Sleep Apnea Physiol Rev, January 1, 2010; 90(1): 47 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Alonso-Fernandez, F Garcia-Rio, M A Arias, A Hernanz, M de la Pena, J Pierola, A Barcelo, E Lopez-Collazo, and A Agusti Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial Thorax, July 1, 2009; 64(7): 581 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lavie and P. Lavie Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link Eur. Respir. J., June 1, 2009; 33(6): 1467 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Dorkova, D. Petrasova, A. Molcanyiova, M. Popovnakova, and R. Tkacova Effects of Continuous Positive Airway Pressure on Cardiovascular Risk Profile in Patients With Severe Obstructive Sleep Apnea and Metabolic Syndrome Chest, October 1, 2008; 134(4): 686 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Sanders, J. M. Montserrat, R. Farre, and R. J. Givelber Positive Pressure Therapy: A Perspective on Evidence-based Outcomes and Methods of Application Proceedings of the ATS, February 15, 2008; 5(2): 161 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gozal and L. Kheirandish-Gozal Cardiovascular Morbidity in Obstructive Sleep Apnea: Oxidative Stress, Inflammation, and Much More Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 369 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yokoe, L. C. Alonso, L. C. Romano, T. C. Rosa, Robert. M. O'Doherty, A. Garcia-Ocana, K. Minoguchi, and C. P. O'Donnell Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic {beta}-cell replication in mice J. Physiol., February 1, 2008; 586(3): 899 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Selmi, N. Montano, R. Furlan, C. L. Keen, and M. E. Gershwin Inflammation and Oxidative Stress in Obstructive Sleep Apnea Syndrome Exp Biol Med, December 1, 2007; 232(11): 1409 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Minoguchi, T. Yokoe, T. Tazaki, H. Minoguchi, N. Oda, A. Tanaka, M. Yamamoto, S. Ohta, C. P. O'Donnell, and M. Adachi Silent Brain Infarction and Platelet Activation in Obstructive Sleep Apnea Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 612 - 617. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |